John G Stratton insider trades: Abbott Laboratories (ABT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | ABT | ↑ Buy | 2,000 | $86.82 | $174K | Direct | Jun 18, 2026 (42d) |
| Dec 17, 2021 | FYBR | ↑ Buy | 5,000 | $29.09 | $145K | Direct | Dec 20, 2021 (3d) |
| Mar 3, 2020 | GD | ↑ Buy | 3,048 | $164.81 | $502K | Direct | Mar 5, 2020 (2d) |
| Jan 31, 2019 | ABT | ↑ Buy | 3,455 | $72.32 | $250K | Direct | Feb 1, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ABT insiders
Open-market trades in the last 12 months
About John G Stratton's insider trades
John G Stratton is a director at Abbott Laboratories (ABT). Since Jan 31, 2019, John has reported 4 open-market purchases worth $1.1M and no sales on SEC Form 4. In the last 12 months: 1 buy ($174K).
Their filings also include grants and awards (339 filings), shares withheld for taxes (17 filings), option exercises (9 filings), other transactions (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.